Pharmacyte Biotech, Inc.
PMCB
Revenue
0.00
0.000.00%
6 Months ChangeAssets
70.19M
▲10.29M▲17.18%
3 Months ChangeLiabilities
17.15M
▼-3.24M▼-15.87%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-17
Form 10-Q
ID: 0001683168-24-006441
2024-05-23
Form 8-K
ID: 0001683168-24-003796
2024-05-01
Form 8-K
ID: 0001683168-24-002881
2024-03-18
Form 10-Q
ID: 0001683168-24-001525
2023-12-15
Form 10-Q
ID: 0001683168-23-008889
2023-11-24
Form 8-K
ID: 0001683168-23-008446
2023-11-16
Form 8-K
ID: 0001683168-23-008204
2023-11-09
Form 8-K
ID: 0001683168-23-007830
2023-09-18
Form 10-Q
ID: 0001683168-23-006505
2023-09-07
Form 8-K
ID: 0001683168-23-006331